|
|
本帖最後由 goodoctor 於 2009-3-4 00:21 編輯
這篇文章再次提醒我們對於中藥在泌尿系統腫瘤中的作用的認識。
編譯:
中草藥藥師腎臟和其他泌尿器官腫瘤的致死率上升
摘要:
背景介紹:台灣的一項「全國性」調查顯示中草藥治療可以增加慢性腎病的可能性,可是還不清楚其對秘尿系統腫瘤的風險,該研究的目的就是論證中草藥在泌尿系統腫瘤方面的風險。
方法:我們研究了在台灣的中草藥藥師,他們都是在1985年到2004年在中草藥工會的登記在冊人員,我們利用「國家」死亡檔案回顧性地跟隨他們的健康狀況以及死亡原因,我們計算了泌尿系統腫瘤的標準死亡率比並且將之與其他台灣正常人與比較。
結果:有6548位中草藥藥師人員登記在冊,在我們觀察的年份里總共年有88289位人員,通過性別和年齡的調整,我們發這些人因泌尿系統腫瘤而死亡的標準死亡率比要比正常人高(SMR = 3.10; 95% CI: 1.41–5.87)。通過進一步定位分類發現,腎癌和其他泌尿器官腫瘤(膀胱癌除外,它的SMR = 2.26; 95% CI: 0.47–6.59)的標準死亡率比明顯升高(SMR = 3.81; 95% CI: 1.39–8.28)。慢性和非特異性腎炎、腎衰竭以及腎硬化也明顯升高(SMR = 2.40; 95% CI: 1.40–3.84)。
結論:中草藥能明顯提高泌尿系統腫瘤方面的風險,這種風險性提示了對中草藥安全性評價方面的迫切需要。
關鍵詞:中草藥;中草藥藥師;馬兜鈴酸、慢性腎病;泌尿系統腫瘤
Journal of Epidemiology
Vol. 19 (2009) , No. 1 pp.17-23
Increased Mortality Risk for Cancers of the Kidney and Other Urinary Organs among Chinese Herbalists
Hsiao-Yu Yang1)2), Jung-Der Wang1)3), Tsai-Chang Lo4) and Pau-Chung Chen1)
Abstract
Background: A national survey in Taiwan has shown that Chinese herbal therapy increases the risk of chronic kidney disease. However, it is unknown whether herbal therapy will increase the risk of urological cancers. The purpose of this study was to determine whether Chinese herbalists are at higher risk for urological cancers.
Methods: We studied all Chinese herbalists in Taiwan that were registered in the Chinese Herbalist Labor Union between 1985 and 2000. We retrospectively followed their survival status and causes of death using the National Mortality Registry Database from 1985 to 2004. Standardized mortality ratios (SMRs) for urological cancers in herbalists were calculated and compared with those of the general population of Taiwan.
Results: A total of 6548 Chinese herbalists were enrolled and 88,289 person-years were accrued during the observation period. After adjustment for age and sex, the SMR for urological cancers was significantly higher for Chinese herbalists than for the general population (SMR = 3.10; 95% CI: 1.41–5.87). When further stratified by location, the SMR for kidney cancer and other urinary organ cancers (SMR = 3.81; 95% CI: 1.39–8.28) except bladder cancer (SMR = 2.26; 95% CI: 0.47–6.59) were significantly higher for the Chinese herbalists. The SMR for chronic and unspecified nephritis, renal failure, and renal sclerosis were also significantly higher for herbalists (SMR = 2.40; 95% CI: 1.40–3.84).
Conclusions: Chinese herbalists have a significantly higher risk for urological cancers. This increased risk among herbalists highlights the urgent need for safety assessments of Chinese herbs.
Key words: Chinese herbal drugs; Chinese herbalist; aristolochic acid; chronic kidney disease; urological cancer
http://www.jstage.jst.go.jp/article/jea/19/1/19_17/_article?s_cid=citation |
|